Ram Waisbourd - Feb 17, 2022 Form 4 Insider Report for 89bio, Inc. (ETNB)

Role
Chief Operating Officer and Chief Business Officer
Signature
/s/ Ryan A. Murr, as attorney-in-fact for Ram Waisbourd
Stock symbol
ETNB
Transactions as of
Feb 17, 2022
Transactions value $
$0
Form type
4
Date filed
2/22/2022, 04:13 PM
Previous filing
Feb 3, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ETNB Common Stock Award $0 +6.25K $0.00 6.25K Feb 17, 2022 Direct F1
transaction ETNB Common Stock Award $0 +2.5K +40% $0.00 8.75K Feb 17, 2022 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ETNB Stock Option (Right to Buy) Award $0 +25K $0.00 25K Feb 17, 2022 Common Stock 25K $4.44 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units ("RSUs") that vest with respect to one-third of the underlying shares on February 17, 2023, with the remaining two-thirds vesting in equal semi-annual installments over the following two years, subject to the Reporting Person's continued service to the Issuer.
F2 Represents RSUs that vest in equal installments on each of August 1, 2022, February 1, 2023 and August 1, 2023.
F3 This option represents a right to purchase a total of 25,000 shares of the Issuer's Common Stock, one quarter of which will vest on February 17, 2023, with the remaining three quarters vesting in equal quarterly installments over the following three years, subject to the Reporting Person's continued service to the Issuer.

Remarks:

Chief Operating Officer and Chief Business Officer